跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Urlyx - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Urlyx
Approved
STANDARD
Urlyx
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5b0c425aac01394b
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
5b0c425aac01394b
Drug Approval Philippines Name
Urlyx
Product Name
Urlyx
Registration Number
DRP-6978
Brand Name
Urlyx
Generic Name
Ursodeoxycholic Acid
Dosage Form
Capsule
Dosage Strength
250 mg
Manufacturer
Lloyd Laboratories, Inc.
Trader
Innogen Pharmaceuticals, Inc.
Issuance Date
25 July 2024
Expiry Date
27 October 2029
Pharmacologic Category
Bile Salt
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5b0c425aac01394b
Type
Standard
Back to Philippines FDA Approvals